GenixPharmaceucticals Corporation Cash Flow Reinvestment Rate

Latest as of April 2020: 9.91x

GenixPharmaceucticals Corporation cash flow reinvestment rate. GenixPharmaceucticals Corporation (GENX) has a Cash Flow Reinvestment Rate of 9.91x as of April 2020, reinvesting CA$1.26 Million (capex CA$0.00 plus investments CA$-1.26 Million) from operating cash flow of CA$126.87K. Explore debt repayment capacity of GenixPharmaceucticals Corporation to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

9.91x
(Capex + Investments) / Operating CF

Total Reinvested

CA$1.26 Million
Capex + Investments

Operating Cash Flow

CA$126.87K
CAD

Capital Expenditures

CA$0.00
CAD

Cash Flow Reinvestment Rate of GenixPharmaceucticals Corporation (2018–2018)

Cash flow reinvestment rate of GenixPharmaceucticals Corporation from 2018 to 2018. Historical reinvestment intensity for GenixPharmaceucticals Corporation across 1 annual periods. Also explore GenixPharmaceucticals Corporation (GENX) equity growth momentum to track the company's year-over-year net asset growth rate.

GenixPharmaceucticals Corporation Cash Flow Reinvestment Rate by Year (2018–2018)

GenixPharmaceucticals Corporation cash flow reinvestment rate by year from 2018 to 2018. Year-by-year capital reinvestment analysis for GenixPharmaceucticals Corporation. For the full cash flow conversion analysis, see cash efficiency ratio of GenixPharmaceucticals Corporation.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2018 1.91x CA$65.34K CA$34.18K CA$0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow